Histone H2A T120 Phosphorylation Promotes Oncogenic Transformation via Upregulation of Cyclin D1.

[1]  S. Armstrong,et al.  Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression Programs. , 2016, Cancer cell.

[2]  P. Lazo,et al.  VRK1 phosphorylates and protects NBS1 from ubiquitination and proteasomal degradation in response to DNA damage. , 2016, Biochimica et biophysica acta.

[3]  A. Bracken,et al.  PRC2 mediated H3K27 methylations in cellular identity and cancer. , 2015, Current opinion in cell biology.

[4]  Sanjay Gupta,et al.  Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment? , 2015, World journal of biological chemistry.

[5]  C. Boshoff,et al.  Molecular Pathways: Targeting the Cyclin D–CDK4/6 Axis for Cancer Treatment , 2015, Clinical Cancer Research.

[6]  P. Lazo,et al.  VRK1 chromatin kinase phosphorylates H2AX and is required for foci formation induced by DNA damage , 2015, Epigenetics.

[7]  G. Sauter,et al.  Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer , 2015, BMC Gastroenterology.

[8]  J. Khadake,et al.  VRK1 interacts with p53 forming a basal complex that is activated by UV‐induced DNA damage , 2014, FEBS letters.

[9]  G. Ning,et al.  Copy Number Variation in CCND1 Gene Is Implicated in the Pathogenesis of Sporadic Parathyroid Carcinoma , 2014, World Journal of Surgery.

[10]  Nouri Neamati,et al.  VprBP has intrinsic kinase activity targeting histone H2A and represses gene transcription. , 2013, Molecular cell.

[11]  Sergio Verjovski-Almeida,et al.  Long non-coding RNAs and their implications in cancer epigenetics , 2013, Bioscience reports.

[12]  R. Pestell.  New roles of cyclin D1. , 2013, The American journal of pathology.

[13]  B. Garcia,et al.  Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma , 2013, Science.

[14]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[15]  Donald W. Anderson,et al.  Cyclin D1 overexpression is associated with poor prognosis in oropharyngeal cancer , 2013, Journal of Otolaryngology - Head & Neck Surgery.

[16]  M. Dawson,et al.  Cancer Epigenetics: From Mechanism to Therapy , 2012, Cell.

[17]  David T. W. Jones,et al.  K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas , 2012, Acta Neuropathologica.

[18]  Y. Xiong,et al.  Vpr-Binding Protein Antagonizes p53-Mediated Transcription via Direct Interaction with H3 Tail , 2011, Molecular and Cellular Biology.

[19]  M. Lisanti,et al.  Reviewing once more the c-myc and Ras collaboration , 2011, Cell cycle.

[20]  Yoshinori Watanabe,et al.  Phosphorylation of H2A by Bub1 Prevents Chromosomal Instability Through Localizing Shugoshin , 2010, Science.

[21]  J. Diehl,et al.  Nuclear cyclin D1: An oncogenic driver in human cancer , 2009, Journal of cellular physiology.

[22]  H. Aburatani,et al.  The Peroxisome Proliferator-Activated Receptor γ/Retinoid X Receptor α Heterodimer Targets the Histone Modification Enzyme PR-Set7/Setd8 Gene and Regulates Adipogenesis through a Positive Feedback Loop , 2009, Molecular and Cellular Biology.

[23]  M. Stratton,et al.  The cancer genome , 2009, Nature.

[24]  R. Assoian,et al.  Transcriptional regulation of the cyclin D1 gene at a glance , 2008, Journal of Cell Science.

[25]  Kyong-Tai Kim,et al.  VRK1 phosphorylates CREB and mediates CCND1 expression , 2008, Journal of Cell Science.

[26]  Ø. Bruserud,et al.  Review: genetic models of acute myeloid leukaemia , 2008, Oncogene.

[27]  Scott A. Armstrong,et al.  MLL translocations, histone modifications and leukaemia stem-cell development , 2007, Nature Reviews Cancer.

[28]  Hengbin Wang,et al.  Regulation of cell cycle progression and gene expression by H2A deubiquitination , 2007, Nature.

[29]  Ali Shilatifard,et al.  Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. , 2006, Annual review of biochemistry.

[30]  Claudio R. Santos,et al.  VRK1 Signaling Pathway in the Context of the Proliferation Phenotype in Head and Neck Squamous Cell Carcinoma , 2006, Molecular Cancer Research.

[31]  S. Baylin,et al.  Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.

[32]  A. Shilatifard,et al.  A COMPASS in the voyage of defining the role of trithorax/MLL‐containing complexes: Linking leukemogensis to covalent modifications of chromatin , 2005, Journal of cellular biochemistry.

[33]  Tsutomu Ohta,et al.  Nucleosomal histone kinase-1 phosphorylates H2A Thr 119 during mitosis in the early Drosophila embryo. , 2004, Genes & development.

[34]  M. Cleary,et al.  Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. , 2003, Genes & development.

[35]  M. Muramatsu,et al.  p300-mediated acetylation facilitates the transfer of histone H2A-H2B dimers from nucleosomes to a histone chaperone. , 2000, Genes & development.

[36]  R. Kobayashi,et al.  ACF consists of two subunits, Acf1 and ISWI, that function cooperatively in the ATP-dependent catalysis of chromatin assembly. , 1999, Genes & development.

[37]  Ryuji Kobayashi,et al.  ACF, an ISWI-Containing and ATP-Utilizing Chromatin Assembly and Remodeling Factor , 1997, Cell.

[38]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[39]  Charles J. Sherr,et al.  Mammalian G1 cyclins , 1993, Cell.

[40]  Steven K. Hanks,et al.  Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins , 1992, Cell.

[41]  Richard A. Ashmun,et al.  Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle , 1991, Cell.

[42]  G. Sauter,et al.  Cyclin D1 gene amplification is highly homogeneous in breast cancer , 2014, Breast Cancer.

[43]  G. Sauter,et al.  CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas , 2013, Clinical Oral Investigations.

[44]  Hideki Ohdan,et al.  Deubiquitylation of histone H2A activates transcriptional initiation via trans-histone cross-talk with H3K4 di- and trimethylation. , 2008, Genes & development.

[45]  E. Álava,et al.  VRK 1 Signaling Pathway in the Context of the Proliferation Phenotype in Head and Neck Squamous Cell Carcinoma , 2006 .